New study aims to sharpen tools for measuring muscle decline in common adult muscular dystrophy

NCT ID NCT07362316

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 30 adults with myotonic dystrophy type 1 (Steinert disease) and 30 healthy volunteers over three years to see how muscle strength and function change naturally over time. Researchers measured things like muscle power, walking ability, and nerve responses to find the most reliable tests for future treatment trials. The goal was not to treat the disease, but to identify the best ways to track progression in future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STEINERT MYOTONIC DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myotonic dystrophy myotonic dystrophy type 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre de recherche du CHU de Québec-Université Laval

    Laval, Canada

  • Institut de Myologie

    Paris, Île-de-France Region, 75013, France